2015 (65 POSTS)

Strickland J, Choksi NY, Allen DG, Casey W. In silico predictions of skin sensitization using OECD QSAR toolbox. Poster presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.

View Abstract

Auerbach SS, Choksi NY, Ferguson S, Hsieh J, Svboda DL, Myatt GJ, et al. HTS and SAR analysis of chemicals from the elk river spill. Poster presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.

View Abstract

2014 (43 POSTS)

Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL, Jensen IS. A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10, ISPOR 17th Annual European Congress 2014.

View Abstract

Haws LC, Thompson C, Perry C, White M, Fitzgerald L, Borghoff S, Wikoff D. Development of non-cancer based toxicity factors and daily dose estimates for TBBPA. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.

View Abstract

Erichsen R, Kelsh MA, Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.

Meddings J, Saint S, Krein S, Gaies E, Reichert H, Hickner A, McNamara S, Mody L. Systematic review of interventions to reduce catheter-associated urinary tract infection in the long-term care setting. Presented at ID Week, Philadelphia, PA, October 2014.

LaPlaca SB, Tufford DL. Assessing the spatial and temporal aspects of buffer capacity in Lake Wateree, SC. Poster presentation at the South Carolina Water Resources Conference, Columbia, SC, October 2014

Kirman CR, Proctor D, Suh M, Thompson CM, Harris MA, Haws LC, Hays SM. Variation analysis of PBPK model parameters for describing the delivery of Cr(VI) to the small intestines of humans. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.

View Abstract

Movva N, Babik I, Galloway JC, Lobo MA. Use of an innovative rehabilitation device for infants to improve upper extremity functionality. Poster presentation at the Undergraduate Research and Service Celebratory Symposium, Newark, DE, August 2014.

Klaren WD, Robertson LW. PCB126-mediated disruption of hepatic metal homeostasis in mice coincides with increased metallothionein expression and appears to be independent of the canonical AhR pathway. Best Poster Award, University of Iowa Research Week, 2014.

Panko JM. Green chemistry: A critical element of sustainable development and product stewardship. Presentation at The American Industrial Hygiene Conference & Exposition (AIHce), San Antonio, TX, June 2014.

Kreider ML, Cyrs WD, Tosiano MA, Panko JM. Method development for nanomaterials exposure assessment in mixed dust environments. Presentation at  American Industrial Hygiene Conference & Exposition (AIHce), San Antonio, TX, May 2014.

Cyrs WD, Tosiano MA, Panko JM, Kreider ML. Use of a novel method to assess exposure to nanoscale carbon black and amorphous silica at two tire manufacturing facilities. Presentation at The American Industrial Hygiene Conference & Exposition (AIHce), San Antonio, TX, June 2014.

Panko JM. Chemical selection tools analysis project and results. Presented at GlobalChem. Global Chemical Regulations Conference, Baltimore, MD, March 2014.

Jensen IS, Bay C, Cyr PL. Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18th Annual International Meeting, New Montreal Quebec, 2014.

Pinto DS, Nicholson G, Harrington RA, Cyr PL, Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.

Jensen IS, Wu C, Bay CB, Cyr PL. Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Reichert H, McMahon LF, Meddings J. Risk-adjusting hospital-acquired pressure ulcer rates from administrative data: How do hospitals perform by the risk-adjusted AHRQ Patient Safety Indicator 3 compared to a proposed measure using risk-standardization applied by the Centers for Medicare and Medicaid Services for other outcomes? Presented at the Academy Health Annual Research Meeting, San Diego, CA, June 2014.